Compare SRPT & FTAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
FTAI Aviation Ltd. 8.25% Fixed - Rate Reset Series C Cumulative Perpetual Redeemable Preferred Shares
Current Price
| Metric | SRPT | FTAIN |
|---|---|---|
| Founded | 1980 | N/A |
| Country | United States | United States |
| Employees | N/A | 580 |
| Industry | Biotechnology: Pharmaceutical Preparations | Misc Corporate Leasing Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | N/A |
| IPO Year | 1997 | N/A |
| Metric | SRPT | FTAIN |
|---|---|---|
| Price | $21.56 | $25.37 |
| Analyst Decision | Hold | |
| Analyst Count | 29 | 0 |
| Target Price | ★ $26.23 | N/A |
| AVG Volume (30 Days) | ★ 3.0M | N/A |
| Earning Date | 11-03-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,413,715,000.00 | N/A |
| Revenue This Year | $13.72 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 47.15 | N/A |
| 52 Week Low | $10.42 | N/A |
| 52 Week High | $129.84 | N/A |
| Indicator | SRPT | FTAIN |
|---|---|---|
| Relative Strength Index (RSI) | 52.20 | 44.77 |
| Support Level | $21.36 | $25.34 |
| Resistance Level | $22.52 | $25.53 |
| Average True Range (ATR) | 1.00 | 0.10 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 48.62 | 31.78 |
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
FTAI Aviation Ltd is an aerospace company. It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft, which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate stable cash flows with the potential for earnings growth and asset appreciation.